Clinical Trial

Effects of Neuralli® MP on Self-Defined Outcomes in Adults With Autistic Traits

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the efficacy of Neuralli® MP in improving participant-defined outcomes in adults with autistic traits.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2025-07-11; most recent amendment 2026-05-29.
Status change: Enrolling by Invitation → Active, Not Recruiting 2026-05-25
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-08-22
Trial Details
NCT Number NCT07064538
Lead Sponsor Mackay Memorial Hospital
Collaborators: Bened Biomedical Co., Ltd.
Conditions ASD, Autism, Autistic Disorders Spectrum
Enrollment 15 participants
Start Date 2025-08-19
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-02